Overview
Chronic Airway Disease, Mucus Rheology and Exacerbations
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2023-05-15
2023-05-15
Target enrollment:
0
0
Participant gender:
All
All
Summary
The main objective of this trial is to compare the exacerbation rates over 12 months of follow-up between a group of patients with COPD treated according to standardized management (standardized comparator arm: azithromycin prescribed in case of severe sputum according to the CASA-Q score) and a similar group in which azithromycin is prescribed according to mucus rheology (experimental arm).Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
University Hospital, MontpellierTreatments:
Azithromycin
Criteria
Inclusion Criteria:- Written and signed informed consent form
- Subjects must be able to attend all planned visits and comply with all test procedures
- Beneficiary of or affiliated with the French social security system
- Man or woman with chronic obstructive pulmonary disease for at least 1 year defined
according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria
and validated by the clinical investigator
- Optimal treatment according to GOLD class severity C or D recommendations
- 1 exacerbation in the past 12 months
- Spontaneous or induced sputum production
- Electrocardiogram: corrected distance between Q and T waves (QTC) <450 ms in men, QTC
<470 ms in women
- Normal audiogram
Exclusion Criteria:
- Pregnancy or breastfeeding
- Patients who are prisoners or under other forms of judicial protection
- Patients under any form of guardianship
- Participation in another interventional protocol, (current or during the month
preceding inclusion)
- Received azithromycin in the past 3 months
- History of allergy or intolerance to macrolides / azithromycin
- Concomitant use of medication contraindicated with azithromycin (dihydroergotamine,
ergotamine, cisapride, colchicine)
- Other respiratory diseases or associated lung infections
- Known history of severe hepatic impairment (a liver function test will be performed in
case of clinical suspicion)